Billemont et al. (2008) suggested that sunitinib affects insulin resistance by interfering with insulin-like growth factor-1 pathway. Louvet et al. (2008) using data from mouse models suggested that inhibition of PDGF downstream-mediated inflammatory response improves pancreatic β-cell survival and insulin resistance. Here, IGF1 is linked to Insulin resistance.